Načítá se...
Sample‐size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review
BACKGROUND: Sample‐size estimation is an important factor in designing a clinical trial. A recent study found that 65% of Cochrane systematic reviews had imprecise results. OBJECTIVE: This study set out to review the whole body of inflammatory bowel disease (IBD) randomised controlled trials systema...
Uloženo v:
| Vydáno v: | United European Gastroenterol J |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8259284/ https://ncbi.nlm.nih.gov/pubmed/33104495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620967899 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|